SOURCE: Crystal Research Associates, LLC

Crystal Research Associates, LLC

June 12, 2007 10:23 ET

Crystal Research Associates, LLC Issues Executive Informational Overview® (EIO®) on Millennium Biotechnologies Group, Inc.

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Crystal Research Associates, LLC.

NEW YORK, NY--(Marketwire - June 12, 2007) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO®) on Millennium Biotechnologies Group, Inc. (OTCBB: MBTG). The full 52-page report can be found at

Millennium Biotechnologies Group, Inc. ("Millennium" or "the Company") engages in the research, development, and marketing of specialized nutritional supplements as an adjunct to medical treatments for select medical conditions, as well as for individuals seeking improved recovery and advanced performance. The Company's marketed products are targeted toward immuno-compromised individuals undergoing medical treatment for diseases, such as cancer, as well as individuals living with Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS) and wound healing and post-surgical healing, among other conditions.

Millennium's three proprietary, marketed products, which form the Company's Resurgex® Continuum of Care, include Resurgex Select®, Resurgex®, and Resurgex Plus®. Resurgex Select® is a whole foods-based, calorically dense, high-protein nutritional formula developed for cancer patients undergoing chemotherapy or radiation treatments. Resurgex® and Resurgex Plus® are specialized, anabolic nutritional supplements rich in antioxidants that provide nutritional support post-treatment. Millennium is also developing a Resurgex® Fusion sports nutrition formula, clinically proven to address the nutritional concerns of both professional and amateur elite athletes. These athletes often experience similar symptoms post-workout to those battling immuno-compromised conditions, such as fatigue, loss of lean muscle, oxidative stress, and reduced immune function. The Company expects to have Resurgex® Fusion on the market by late 2007, with potential marketing agreements with the National Collegiate Athletic Association (NCAA) and other pro-athletic organizations thereafter. Millennium is headquartered in Basking Ridge, NJ and trades on the Over-the-Counter (OTC) market under the symbol "MBTG.OB."

About Crystal Research Associates, LLC

Crystal Research Associates, LLC is an independent research firm that provides institutional-quality, fee-based research to small and mid-cap companies. Crystal Research Associates' unique and novel product, the Executive Informational Overview® (EIO®), is free of investment ratings, target prices, and forward-looking financial models. The EIO® presents a crystal clear, detailed report on a company (public or private) in a manner that is easily understood by the Wall Street financial community. The EIO® details a company's product/technology/service offerings, market size(s), key intellectual property, leadership, growth strategy, competition, risks, audited financial statements, key events, and other such fundamental information. Crystal Research Associates has offices in New York City, Delray Beach, Montréal, and Toronto. Crystal Research Associates has been compensated by the Company in cash of forty thousand dollars and three hundred thousand Warrants/Options for its services in creating this base report, for quarterly updates, and for printing costs.

Forward-Looking Safe Harbor Statement

Statements in this news release regarding future financial and operating results, future growth in R&D programs, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of the Company's intellectual property, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports, including Forms 10-KSB, 10-QSB, 8-K, and other forms filed with the Securities and Exchange Commission ("SEC").

These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties. Crystal Research Associates assumes no obligation to update any of the forward-looking statements in this release.

Contact Information

  • Contact:
    Jeffrey J. Kraws
    Email Contact
    Karen B. Goldfarb
    Email Contact
    Crystal Research Associates, LLC
    P: (609) 306-2274
    F: (609) 395-9339